Quantcast

Latest ovarian cancer Stories

2014-06-11 08:29:54

All 9 Out Of 9 Patients Who Have Reached 4 Injections Are Showing Tumor Cell Death, Tumor Shrinkage And/Or Stabilization Of Disease BETHESDA, Md., June 11, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that, in the ongoing Phase I/II clinical trial of DCVax-Direct for all types of inoperable solid tumors, all 9 out of 9 patients who have...

2014-06-10 16:29:08

Kelly Ripa Stars in Public Service Announcements for "QVC Presents Super Saturday LIVE," Benefitting Ovarian Cancer Research Fund WEST CHESTER, Pa., June 10, 2014 /PRNewswire/ -- Kelly Ripa is shopping to save lives as she fills up her bag with designer deals that will contribute to the cure for ovarian cancer. Ripa, one of the most renowned hosts in morning television, will appear in both the print and television public service announcements promoting "QVC Presents Super Saturday...

2014-06-09 23:09:24

In CHAMPS Oncology's most recent blog post, Cancer Registry on the TODAY Show, Rhonda Spoden shares her thoughts on the topic. Cleveland, OH (PRWEB) June 09, 2014 In CHAMPS Oncology's most recent blog post, Cancer Registry on the TODAY Show, Rhonda Spoden shares her thoughts on the topic. It isn’t often the cancer registry makes national headlines, and (as much as she loves and respects the profession) Spoden never expected to hear about the cancer registry on the TODAY Show....

2014-06-09 12:31:07

TSX Venture: QPT EDMONTON, June 9, 2014 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, reports today that patient enrollment has been completed in the Company's Phase IIb clinical trial of its lead immunotherapy product candidate Oregovomab for the treatment of Ovarian Cancer. "I am pleased that we have reached this important milestone in our clinical program"...

2014-06-05 08:28:09

Median Overall Survival was 8 Years Longer for Women who were Treated with Therapies Consistent with Caris Molecular Intelligence(TM) Tumor Profiling Prediction and was 2 ½ years Longer after Recurrence IRVING, Texas, June 5, 2014 /PRNewswire/ -- Caris Life Sciences® and investigators from Inova Fairfax Hospital presented the first clinical outcomes data presentation from the Caris Registry(TM) at the 50(th) annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago,...

2014-06-03 23:09:20

Inhibiting enzymes that cause changes in gene expression could decrease chemotherapy resistance in ovarian cancer patients, researchers at Georgia State University and the University of Georgia say. Atlanta, Georgia (PRWEB) June 03, 2014 Inhibiting enzymes that cause changes in gene expression could decrease chemotherapy resistance in ovarian cancer patients, researchers at Georgia State University and the University of Georgia say. Dr. Susanna Greer, associate professor of biology, and...

2014-06-03 12:27:34

Institute of Cancer Research Around a quarter of smokers who carry a defect in the BRCA2 gene will develop lung cancer at some point in their lifetime, a large-scale, international study reveals. Scientists announce a previously unknown link between lung cancer and a particular BRCA2 defect, occurring in around 2 per cent of the population, in research published in Nature Genetics today (Sunday). The defect in BRCA2 - best known for its role in breast cancer - increases the risk of...

2014-06-03 11:48:40

University of Colorado Denver At the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 (FZD8-Fc), an investigational drug candidate discovered by OncoMed Pharmaceuticals targeting cancer stem cells (CSCs). The drug was generally well tolerated, and several of the 26 patients with advanced solid tumors experienced stable disease for greater than six months. Three trials...

2014-06-03 08:31:33

ROCKVILLE, Md., June 3, 2014 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that Franklin C. Salisbury, Jr. has joined the Company's Board of Directors. http://photos.prnewswire.com/prnvar/20010620/ENMDLOGO Since 1998, Mr. Salisbury has served as president of the National Foundation for Cancer Research (NFCR), an organization that supports healthcare...

2014-06-02 23:08:13

Ovarian Cyst Miracle is a new treatment method created by Carol Foster that claims to help women reduce PCOS symptoms naturally and quickly. A complete review on the site hynguyenblog.com shows whether this method is safe or not. New York, NY (PRWEB) June 02, 2014 Ovarian Cyst Miracle book is the latest e-book for ovarian cysts sufferers that wish to know how to get rid of all types of ovarian cysts such as follicular cysts, cyst adenoma, corpus luteum cysts, and hemorrhagic cysts. In...


Latest ovarian cancer Reference Libraries

Ovaries
2013-03-05 14:55:04

The ovaries are the two reproductive female organs where the eggs are produced. These are parallel to the testes in men. Formation and Orientation Each ovary is the size of an almond and is located on one side of the pelvis before the ureter and internal iliac artery but after the external iliac artery. They are attached to either side of the uterus. They are connected and release eggs to fallopian tubes, though not attached, monthly during the menstrual cycle. They also produce...

More Articles (1 articles) »
Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related